Call 1-877-744-5675

For specific access issues

Pfizer Oncology Field Reimbursement Managers (FRMs) are trained resources who can help address specific access issues—in person or over the phone. They can help educate your staff on our access and reimbursement resources and help address challenging or urgent Pfizer Oncology patient cases you have sent us.

Contact a Pfizer Oncology Field Reimbursement Manager

Call us or let your Pfizer Oncology Account Specialist know if you’d like to get in touch with an FRM in your area.

Please see full Prescribing Information for SUTENT® (sunitinib malate), including BOXED WARNING for hepatotoxicity, or visit SUTENThcp.com.

Please see full Prescribing Information for DAURISMO (glasdegib), including BOXED WARNING for embryo-fetal toxicity, or visit DAURISMOhcp.com.

Please see full Prescribing Information for BESPONSA® (inotuzumab ozogamicin), including BOXED WARNING for hepatotoxicity, including VOD, and increased risk of post-HSCT non-relapse mortality, or visit BESPONSAhcp.com.

Please see full Prescribing Information for MYLOTARG (gemtuzumab ozogamicin), including BOXED WARNING for hepatotoxicity, or visit MYLOTARGhcp.com.

BACK TO TOP